Skip to main content

Caption Management, LLC

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1706766 OKLAHOMA CITY, OK

Position in KALV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$1,904,198 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
8 quarters on record

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Derivatives in KALV

reported options exposure · as of Mar 31, 2026
CallValue
$28,785,900
CallShares
1,430,000
PutValue
$20,130,000
PutShares
1,000,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Caption Management, LLC holds $196,103,961 across 70 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,130,000 1,000,000
2026-03-31 $28,785,900 1,430,000
2025-12-31 $1,904,198 117,907
2025-09-30 $7,083,888 581,600
2025-09-30 $1,722,519 141,422
2025-09-30 $10,530,828 864,600
2025-03-31 $5,193,000 450,000
2023-12-31 $4,844,875 395,500
2023-12-31 $2,021,250 165,000
2023-12-31 $4,000,850 326,600
2023-09-30 $3,481,245 361,500
2023-09-30 $1,231,349 127,866
2023-09-30 $3,854,889 400,300
2022-12-31 $115,859 17,139
2022-09-30 $2,031,400 140,000